International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8360675
Original Article
Study on Clinico-Epidemiology and Quality of Life in Patients of Acne Vulgaris in a Tertiary Health Care Centre
 ,
 ,
 ,
 ,
 ,
Published
Sept. 18, 2023
Abstract

Background: Acne is a chronic multifactorial inflammatory disorder of pilosebaceous unit. It is frequently seen in adolescents and young adults. Acne leads to significant psychological distress, social anxiety and impairs quality of life in patients

Aim: To assess demographic variables and Quality of life in patients with Acne vulgaris.

Method: This was a hospital-based, observational, pre-structured, questionnaire-based study done in 1015 patients who attended the Skin and VD, OPD of Mahatma Gandhi Medical College and Hospital, from January 2021 to June 2022.

Results: A total of 1015 patients were included in the study with a female to male ratio of 1.2:1. The age of the patients ranged from 14-35 years. Majority of the study participants were students (51.4%). Most common site affected was face (68%). Dermatology life quality index (DLQI) score ranged from from 1 to 20 with mean score of 8.18 ± 4.45. Overall quality of life assessment showed moderate to very large effect in patients with Acne Vulgaris depending on the severity of the disease.

Conclusion: Acne Vulgaris negatively impacts quality of life. This effect is more pronounced in female patients and young adults with severe acne. Proper counselling and psycho-social support should be provided to improve the Quality of life in these patients.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
191 Views
253 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved